Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL618388 | 0.94 | HSD17B10 (0.35) | HSD17B10MEN1POLBKMT2A | |
| SCHEMBL11794541 | 0.91 | HSD17B10 (0.33) | HSD17B10 | |
| SCHEMBL7509652 | 0.88 | — | — | |
| SCHEMBL10337467 | 0.84 | HTT (0.46) | MEN1KMT2ATDP1 | |
| SCHEMBL11208961 | 0.83 | HSD17B10 (0.32) | HSD17B10MEN1KMT2ATDP1 | |
| SCHEMBL8729561 | 0.83 | — | — | |
| SCHEMBL615634 | 0.81 | TSHR (0.48) | MEN1KMT2A | |
| SCHEMBL8744210 | 0.80 | HSD17B10 (0.38) | HSD17B10MEN1POLBKMT2ATDP1 | |
| SCHEMBL8744207 | 0.80 | HSD17B10 (0.38) | HSD17B10MEN1POLBKMT2ATDP1 | |
| SCHEMBL13179378 | 0.80 | HSD17B10 (0.38) | HSD17B10MEN1POLBKMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120037860-A1 | DYE-CONTAINING NEGATIVE CURABLE COMPOSITION, COLOR FILTER AND METHOD FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2012-02-16 | — | — | US | disclosed |
| US-8057969-B2 | Dye-containing negative curable composition, color filter and method for producing the same | FUJIFILM CORPORATION (JP) | 2011-11-15 | — | — | US | disclosed |
| US-7914956-B2 | Dye-containing negative working curable composition, color filter and production method thereof | FUJIFILM CORPORATION (JP) | 2011-03-29 | — | — | US | disclosed |
| US-7910272-B2 | Dye-containing photosensitive composition, color filter using the same, and production method thereof | FUJIFILM CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | SHISEIDO COMPANY LTD. (JP) | 2011-01-06 | — | — | US | disclosed |
| EP-2255780-A1 | PARAKERATOSIS INHIBITOR, PORE SHRINKING AGENT OR AGENT FOR PREVENTING OR IMPROVING ROUGH SKIN, AND COMPOSITION FOR EXTERNAL USE ON THE SKIN CONTAINING THE SAME | Shiseido Company, Ltd. (JP) | 2010-12-01 | — | — | EP | disclosed |
| US-7645545-B2 | Colorant-containing curable composition, color filter and production method thereof | FUJIFILM CORPORATION (JP) | 2010-01-12 | — | — | US | disclosed |
| US-20090273741-A1 | OPTICAL MATERIAL HAVING A COLORED OPTICALLY ANISOTROPIC LAYER | FUJIFILM CORPORATION (JP) | 2009-11-05 | — | — | US | disclosed |
| EP-2113807-A2 | Optical material having a colored optically anisotropic layer | Fujifilm Corporation (JP) | 2009-11-04 | — | — | EP | disclosed |
| US-7575837-B2 | Colored curable composition, color filter and method for producing the same | FUJIFILM CORPORATION (JP) | 2009-08-18 | — | — | US | disclosed |
| US-20070254240-A1 | Dye-containing negative curable composition, color filter and method for producing the same | FUJIFILM CORPORATION (JP) | 2007-11-01 | — | — | US | disclosed |
| EP-1850178-A2 | Dye-containing negative curable composition, color filter and method for producing the same | FUJIFILM Corporation (JP) | 2007-10-31 | — | — | EP | disclosed |
| US-20070212623-A1 | Dye-containing negative working curable composition, color filter and production method thereof | FUJIFILM CORPORATION (JP) | 2007-09-13 | — | — | US | disclosed |
| US-20070190435-A1 | Dye-containing photosensitive composition, color filter using the same, and production method thereof | FUJIFILM CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070099096-A1 | Dye-containing curable composition, color filter and method of producing thereof | FUJIFILM CORPORATION | 2007-05-03 | — | — | US | disclosed |
| US-20070072096-A1 | Negative curable dye-containing composition, color filter, and method of manufacturing the same | FUJI PHOTO FILM CO., LTD. | 2007-03-29 | — | — | US | disclosed |
| EP-1741756-A1 | TETRAAZAPORPHYRIN COMPOUND | Yamamoto Chemicals, Inc. (JP) | 2007-01-10 | — | — | EP | disclosed |
| US-20060257762-A1 | Colored curable composition, color filter and method for producing the same | FUJI PHOTO FILM CO., LTD. | 2006-11-16 | — | — | US | disclosed |
| US-20060246364-A1 | Colorant-containing curable composition, color filter and production method thereof | FUJI PHOTO FILM CO., LTD. | 2006-11-02 | — | — | US | disclosed |
| US-4432946-A | Uranium (VI) recovery process using acid organophosphorus extractant containing two or four alkoxyalkyl or aryloxyalkyl radicals | COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) | 1984-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110004019-A1 | Parakeratosis Inhibitor, Pore-Shrinking Agent, Or Rough Skin Inhibiting/Ameliorating Agent, And External Composition For Skin Containing The Same | CUTA, GLRA3, ARGLU1 | HSD17B10 2609/4885MEN1 2738/4885POLB 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.